Article Archive - Page 50 of 63 - Business Chemistry

The Effects of the Financial Crisis on the Future of the Chemical Industry

by | Feb 2009

The chemical industry is also feeling more and more strongly the effects of the financial crisis and the recession in the important markets of the world. Even so, “horror” scenarios are not appropriate. The marked decrease in the oil price is also having a positive...

Mergers & Acquisitions (M&A) in the Pharmaceutical and Chemical Industries: A Lighthouse in Choppy Waters

by | Feb 2009

After record years in 2006 and 2007 that even topped the peak-year 2000, a cooling down of the international market for Mergers and Acquisitions (M&A) could be observed in 2008: Whilst the global transaction volume in 2007 reached about $ 4,400 bn. (2006: $ 3,600...

Open Source Biopharmaceutical Innovation – A Mode of Entry for Firms in Emerging Markets

by | Feb 2009

The open source model provides a valuable framework for collective knowledge production and dissemination. Mirroring the efforts of the open source community that developed Linux, open biopharmaceutical initiatives are enabling companies to access knowledge-based...

Biotechnology Research in South Africa: A Benchmarking Exercise

by | Feb 2009

Biotechnology has been identified as a priority area for the national innovation system in South Africa. Since 2003 new structures have been established in the country in order to enhance biotechnology research and innovation in accordance with the “National...

REACH Effects – Opportunities and Risks for Transfer Pricing

by | Feb 2009

1 Introduction This article gives a general background to the REACH regulation and reflects on the possible impact of REACH on Transfer Pricing opportunities and risks. REACH stands for Registration, Evaluation and Authorisation of CHemicals. Since REACH may provide...

« Older Entries

Next Entries »